Doyle Wealth Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-14
Closed -$1K 821
2019
Q2
$1K Buy
+14
New +$2.43K ﹤0.01% 841
2019
Q1
Sell
-14
Closed -$5K 818
2018
Q4
$5K Buy
+14
New +$10.9K ﹤0.01% 736

Other funds holding HSTO

Doyle Wealth Management's HSTO Position: Q3 2019 in Review

Doyle Wealth Management sold out of Histogen Inc. Common Stock (HSTO) in Q3 2019, closing a stake of 14 shares — an estimated $1K sold.

Doyle Wealth Management first reported a position in HSTO in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q4 2018. 29 funds tracked by Wall St. Rank hold HSTO as of Q3 2019.

  • Doyle Wealth Management reported no remaining Histogen Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Doyle Wealth Management sold 14 Histogen Inc. Common Stock shares in Q3 2019, an estimated $1K.
  • Doyle Wealth Management first reported a position in Histogen Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • Doyle Wealth Management's Histogen Inc. Common Stock position peaked at $5K in Q4 2018.
  • 29 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2019.

Based on Doyle Wealth Management's 13F filing for Q3 2019, filed 5 Nov 2019.